XML 56 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Business Combination - Schedule of Consideration (Details) - USD ($)
$ in Thousands
Dec. 04, 2025
Mar. 31, 2026
Dec. 31, 2025
Business Combination, Separately Recognized Transaction [Line Items]      
Fair value of contingent consideration   $ 125,554 $ 118,360
Goodwill $ 141,100    
Foresight Diagnostics, Inc.      
Business Combination, Separately Recognized Transaction [Line Items]      
Fair value of common stock issued to Foresight Diagnostics shareholders 273,038    
Pre-combination portion of Natera replacement equity awards 12,088    
Fair value of contingent consideration 118,360 $ 125,600 $ 118,400
Estimated fair value of the adjustment escrow shares 2,300    
Stockholder representative allocable expenses 1,000    
Foresight Diagnostics’ transaction expenses settled by the Company 7,232    
Foresight Diagnostics’ indebtedness settled by the Company 5,974    
Settlement of preexisting relationships 4,542    
Cash payment for fractional shares 2    
Total Foresight Diagnostics consideration 424,536    
Cash and cash equivalents 2,727    
Current assets 8,126    
Property and equipment, net 7,224    
Goodwill 141,070    
Developed technology intangible asset 335,300    
Customer relationships intangible asset 900    
Trademarks / trade names intangible asset 500    
Operating lease right-of-use assets 11,261    
Other assets 1,291    
Liabilities assumed (22,397)    
Deferred tax liability $ (61,466)